Abstract
The prognosis of pancreatic adenocarcinoma is poor and current treatment ineffective. A novel treatment strategy is described here using a mouse model system for pancreatic cancer. Cells that have been genetically modified to express the cytochrome P450 2B1 enzyme are encapsulated in cellulose sulphate and implanted into pre-established tumours derived from human pancreatic cells. Cytochrome P450 2B1 converts the chemotherapeutic agent ifosfamide to toxic metabolites. Administration of ifosfamide to tumour-bearing mice that were recipients of implanted encapsulated cells results in partial or even complete tumour ablation. These results suggest that in situ chemotherapy with genetically modified cells in an immunoprotected environment may prove useful for application in man.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Löhr, M., Müller, P., Karle, P. et al. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450. Gene Ther 5, 1070–1078 (1998). https://doi.org/10.1038/sj.gt.3300671
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300671
Keywords
This article is cited by
-
Sodium cellulose sulfate: A promising biomaterial used for microcarriers’ designing
Frontiers of Chemical Science and Engineering (2019)
-
Genetisch modifizierte Zellen zur Therapie verschiedener Erkrankungen
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2015)
-
Feasibility of carboxymethylcellulose with phenol moieties as a material for mammalian cell-enclosing subsieve-size capsules
Cellulose (2008)
-
Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide
Cancer Gene Therapy (2006)